SEER Seer, Inc.
Laboratory Analytical Instruments · Nasdaq · SEC CIK 1726445 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-14.0%
TTM net income YoY20.0%
TTM EPS YoY—
Revenue 3-yr CAGR-5.8%
Net income 3-yr CAGR—
Margins
Gross margin46.5%
Operating margin-469.9%
Net margin-450.9%
FCF margin-329.3%
EBITDA margin-438.2%
Returns
ROE-26.2%
ROA-23.1%
ROIC (approx.)-25.5%
Asset turnover0.05x
Leverage & solvency
Liabilities / assets12.0%
Debt / equity0.00x
Current ratio16.89x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.71x
Accruals ratio-6.6%
Payout ratio—
Capex / revenue7.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $16.58M | $14.17M | $16.66M | $15.49M | $6.62M |
| Cost of revenue | $8.11M | $7.12M | $8.15M | $8.40M | $3.21M |
| Gross profit | $8.46M | $7.05M | $8.51M | $7.09M | $3.41M |
| R&D expense | $43.87M | $50.59M | $53.02M | $45.80M | $29.12M |
| SG&A expense | $42.58M | $56.57M | $58.95M | $58.53M | $45.76M |
| Operating income | -$77.99M | -$100.10M | -$103.46M | -$97.23M | -$71.47M |
| Interest expense | — | — | — | $0 | $22,000 |
| Pretax income | -$73.40M | -$86.50M | -$86.28M | — | — |
| Income tax | $201,000 | $98,000 | $0 | $0 | $0 |
| Net income | -$73.60M | -$86.60M | -$86.28M | -$92.97M | -$71.17M |
| EBITDA | -$72.87M | -$94.27M | -$98.11M | -$93.33M | -$68.87M |
| EPS (basic) | — | — | -1.35 | -1.49 | -1.17 |
| EPS (diluted) | — | — | -1.35 | -1.49 | -1.17 |
| Dividends declared per share | 0.00 | 0.00 | 0.00 | — | — |
| Weighted avg. shares (diluted) | — | — | 63.85M | 62.43M | 60.86M |
| Balance sheet | |||||
| Cash & equivalents | $47.28M | $41.28M | $33.02M | $53.73M | $233.34M |
| Short-term investments | $138.61M | $195.66M | $283.73M | $368.03M | $167.26M |
| Receivables | — | — | $4.83M | $4.32M | $2.50M |
| Inventory | $7.79M | $7.44M | $4.49M | $4.63M | $4.14M |
| Current assets | $201.53M | $253.32M | $330.51M | $434.98M | $411.70M |
| PP&E, net | $14.75M | $18.57M | $22.19M | $19.41M | $13.09M |
| Total assets | $296.08M | $366.60M | $436.27M | $487.93M | $539.14M |
| Current liabilities | $15.69M | $15.33M | $13.22M | $12.58M | $13.42M |
| Total liabilities | $36.78M | $39.03M | $39.37M | $40.94M | $36.22M |
| Shareholders' equity | $259.31M | $327.57M | $396.90M | $446.99M | $502.92M |
| Shares outstanding | — | — | — | 63.41M | 62.02M |
| Cash flow statement | |||||
| Operating cash flow | -$44.45M | -$46.11M | -$59.06M | -$60.78M | -$46.35M |
| Capital expenditure | $1.80M | $3.58M | $7.31M | $10.27M | $6.92M |
| Free cash flow | -$46.24M | -$49.69M | -$66.37M | -$71.05M | -$53.27M |
| Investing cash flow | $61.55M | $65.86M | $37.90M | -$122.72M | -$170.88M |
| Financing cash flow | -$10.57M | -$11.49M | $452,000 | $3.89M | $116.63M |
| Depreciation & amortization | $5.12M | $5.84M | $5.35M | $3.90M | $2.60M |
| Stock-based compensation | $15.41M | $28.21M | $34.42M | $33.67M | $25.93M |
| Share buybacks | — | $0 | $13,000 | $20,000 | $35,000 |
Free plan shows the latest 5 periods; Pro shows all 6 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.